A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2011
11/09/2011	EP2384334A1 A method of producing a novel opioid peptide
11/09/2011	EP2384200A1 Alanine-glyoxylate aminotransferase therapeutics
11/09/2011	EP2384199A1 Enhanced medical implant
11/09/2011	EP2384116A1 Dominant negative wnt2 compositions and methods of use
11/09/2011	EP2384113A1 A composition comprising nor-adrenaline and amphetamine for administering to a brain-dead, heart -beating potential organ donor
11/09/2011	EP2384112A1 A composition comprising nor-adrenaline and a net inhibitor for administering to a brain-dead, heart-beating potential organ donor.
11/09/2011	EP1813623B1 Purinenucleoside derivative modified in 8-position and medicinal use thereof
11/09/2011	EP1773452B1 Lysis / resealing process for incorporating an active ingredient in erythrocytes
11/09/2011	EP1641813B1 Methods for obtaining molecules with reduced immunogenicity
11/09/2011	EP1592796B1 Helminth-derived antigens having capacity of providing protection against parasites
11/09/2011	EP1539817B1 Immunoassays for specific determination of scca isoforms
11/09/2011	EP1432794B1 Human coagulation factor vii polypeptides
11/09/2011	EP1328624B1 B7-like molecules and uses thereof
11/09/2011	EP1062337B1 Human n-type calcium channel isoform and uses thereof
11/09/2011	EP1001815B1 Vectors derived from antibodies for transferring substances into cells
11/09/2011	CN1984675B Pharmaceutical compositions comprising botulinum neurotoxin, a non ionic surfactant, sodium chloride and sucrose
11/09/2011	CN1913924B Solid sustained-releasing formulation comprising triptorelin acetate
11/09/2011	CN1845920B 2-amido-4-aryloxy-1-carbonylpyrrolidine derivatives as inhibitors of serine proteases, particularly HCV NS3-NS4A protease
11/09/2011	CN1802385B Template-fixed beta-hairpin peptidomimetics with CXCR4 antagonizing activity
11/09/2011	CN102239414A Methods and uses involving heme binding protein 1
11/09/2011	CN102239253A Glutamyl trna synthetase (GTS) fragments
11/09/2011	CN102239179A Integrin peptide, anti-cd 18 ssa antibody for treatment of endotoxin-mediated pro-inflammatory responses and the use
11/09/2011	CN102239173A Methods related to modified glycans
11/09/2011	CN102238958A Inhalant comprising modified superoxide dismutase
11/09/2011	CN102238957A Method and composition for enhancement of male erectile function
11/09/2011	CN102238947A Nutrient composition
11/09/2011	CN102234638A Modified maize ribosome-inactivating protein precursor and application as well as protein purification method thereof
11/09/2011	CN102234334A Immunoglobulin chimeric monomer - dimer heterozygote
11/09/2011	CN102234331A Composition of Exendin-4 derivative and preparation method and application thereof
11/09/2011	CN102234316A Polypeptides capable of enhancement of acid sensing ion channels 1a current, and use thereof
11/09/2011	CN102234315A Modified endomorphin-1 compound and application in easing pain thereof
11/09/2011	CN102234314A Method for preparing a group of snake venom derived active peptides and application of active peptides in anti-tumor aspect
11/09/2011	CN102233135A Heightening substance coagulant
11/09/2011	CN102233134A Slit-Robo-mediated lymph vessel formation and application
11/09/2011	CN102233132A Application of VEGF acceptor fusion proteins in preparation of drugs for inhibiting growth of ocular surface neovascularization
11/09/2011	CN102233130A Stable pharmaceutical preparation containing thymosin 1 derivatives
11/09/2011	CN102233129A Long-acting sustained release preparation for preventing or treating retinal damage, and preparation method thereof
11/09/2011	CN102233128A Use of p75neurotrophin receptor-extracellular domain (p75NTR-ECD) in medicine for preventing and treating Alzheimer disease
11/09/2011	CN101891811B Shark angiogenesis inhibiting factor and production and purification method and application
11/09/2011	CN101856323B Beta-CD inclusion suppository containing rana chensinensis antibacterial peptide and preparation method thereof
11/09/2011	CN101693888B Yellow mealworm plasmin and preparation method and applications thereof
11/09/2011	CN101597290B Beta-carboline-3-formyl tryptophyl amine acid carbamate as well as preparation method and application thereof
11/09/2011	CN101591375B Compound with analgesic activity, preparation method and application thereof
11/09/2011	CN101585864B Nitrogen-terminal fixed-point coupling method for colony stimulating factor of column chromatography granulocyte and coupled product
11/09/2011	CN101536982B Trastuzumab-modified toxin protein-coated PEG immune liposome and preparation and application thereof
11/09/2011	CN101456902B Microorganism metabolites feed supplement cyclic decapeptide and application
11/09/2011	CN101392026B Polypeptide for preventing and treating fibrotic disease and liver cancer
11/09/2011	CN101343251B Thrombopoietin mimetics
11/09/2011	CN101265298B Endothelium chalone mutant containing non-natural amino acid and derivatives thereof
11/09/2011	CN101217971B Treatment of tumors
11/09/2011	CN101200493B (3S)-N-(L-aminoacyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, preparation method and uses thereof
11/08/2011	US8053568 Bacterial packaging strains useful for generation and production of recombinant double-stranded RNA nucleocapsids and uses thereof
11/08/2011	US8053564 Biological effectors; S-[3-({2-(3-{[3-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)propanoyl]amino}propoxy)-1,1-bis[3-{[3-(2,5-dioxo-2,5-dihydro-1 H-pyrrol-1-yl)propanoyl]amino}propoxy)methyl]ethyl}amino)-3-oxopropyl]ethanethioate
11/08/2011	US8053561 Pegylated factor VIII
11/08/2011	US8053560 Modified human plasma polypeptide or Fc scaffolds and their uses
11/08/2011	US8053558 Dendritic cell co-stimulatory molecules
11/08/2011	US8053557 SPARC-derived tumor rejection antigenic peptides and medicaments comprising the same
11/08/2011	US8053556 Glypican-3 (GPC3)-derived tumor rejection antigenic peptides useful for HLA-A2-positive patients and pharmaceutical comprising the same
11/08/2011	US8053555 Carbon nanotube binding peptides
11/08/2011	US8053554 Peptide nanostructures and methods of generating and using the same
11/08/2011	US8053552 Neopeptides and methods useful for detection and treatment of cancer
11/08/2011	US8053551 Comprises six transmembrane epithelial antigen of the prostate-2 protein (STEAP)) for diagnosis and treatment of cell proliferative and tumor disorders; genetic vaccine; antitumor agents
11/08/2011	US8053476 Method for treating peripheral neuropathic pain
11/08/2011	US8053415 Compounds having RD targeting motifs
11/08/2011	US8053414 Methods of using B7-DC molecules to induce or enhance an immune response
11/08/2011	US8053413 Ameliorating breathing disorder using cholecystokinin (CCK) receptor antagonist
11/08/2011	US8053412 NELL-1 peptides
11/08/2011	US8053411 Method of treating dyspnea associated with acute heart failure
11/08/2011	US8053410 Pegylated factor VII glycoforms
11/08/2011	US8053409 Agent for prophylaxis of reflex sympathetic dystrophy after cerebral apoplexy
11/08/2011	US8053408 Methods for treating obesity using fibroblast growth factor-like polypeptides
11/08/2011	US8053407 Methods of treating neurological conditions with hematopoeitic growth factors
11/08/2011	US8053233 Host cells expressing IL-18 receptors
11/08/2011	US8053209 FRET protease assays for clostridial toxins
11/08/2011	US8053208 FRET protease assays for clostridial toxins
11/08/2011	US8053206 Antagonists of HMG1 for treating inflammatory conditions
11/08/2011	US8052998 Mixture of biodegradable polymer and cationic polymer
11/08/2011	US8052980 Use of the neurotoxic component of a botulinum toxin for treating arthritis
11/08/2011	US8052976 Growth factor homolog ZVEGF3
11/08/2011	US8052975 Compounds and methods for treatment and diagnosis of chlamydial infection
11/08/2011	US8052972 Remedies for inflammatory bowel diseases
11/08/2011	US8052970 Lysosomal phospholipase A2 (LPLA2) activity as a diagnostic and therapeutic target for identifying and treating systemic lupus erythematosis
11/08/2011	US8052964 Interferon-β mutants with increased anti-proliferative activity
11/08/2011	US8052961 Highly fluorinated β-amino acids and methods of making and using same
11/08/2011	CA2702431C Ready-to-use bivalirudin compositions
11/08/2011	CA2653201C Compositions and uses of e3-gp19k for treating diabetes
11/08/2011	CA2636075C Chimaeric fusion protein with superior chaperone and folding activities
11/08/2011	CA2528312C Methods of managing the symptoms of premenstrual syndrome
11/08/2011	CA2526594C Use of tyrosine kinase inhibitors to treat diabetes
11/08/2011	CA2459230C Peptidic compounds selectively binding to p-selectin
11/08/2011	CA2455655C A glycoprotein with antidiabetic, antihypertensive, antiobesity and antihyperlipidemic effects from grifola frondosa, and a method for preparing same
11/08/2011	CA2442182C Modulation of pd-1 interactions with its ligands
11/08/2011	CA2413698C Endoparasiticidal agents for voluntary oral ingestion by animals
11/08/2011	CA2399100C Purified lh
11/08/2011	CA2343414C Fc receptor modulators and uses thereof
11/08/2011	CA2302255C Fracture healing using pthrp analogs
11/08/2011	CA2249596C Methods for enhancing functional recovery following central nervous system ischemia or trauma
11/08/2011	CA2247285C Human tumor necrosis factor delta and epsilon
11/08/2011	CA2246352C Methods for inhibiting an immune response by blocking the gp39/cd40 and ctla4/cd28/b7 pathways and compositions for use therewith
11/08/2011	CA2153692C Recombinant anti-vla4 antibody molecules

1 ... 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 ... 3163